Target intelligence / Profile preview

RNA, U1 small nuclear 17, pseudogene (RNU1-17P)

Target
RNU1-17P
Molecular classification
Other, Non-coding RNA, Small nuclear RNA (snRNA), Pseudogene
01

Overview

RNA, U1 small nuclear 17, pseudogene (RNU1-17P) is a genomic sequence classified as a pseudogene of the U1 small nuclear RNA (snRNA) gene family[1][4]. U1 snRNA is an essential component of the spliceosome, responsible for recognizing 5’ splice sites and initiating pre-mRNA splicing; however, pseudogenes like RNU1-17P traditionally have been considered non-functional genetic elements, as they typically contain sequence defects that prevent them from encoding functional RNA[4]. Recent studies suggest that some U1 snRNA pseudogenes are transcribed, can generate structurally variant RNAs, are incorporated into ribonucleoprotein complexes, and might play nuanced regulatory roles in specific cell types by influencing mRNA processing or acting as RNA decoys[4]. For RNU1-17P specifically, there is no known direct functional role, established disease association, or status as a therapeutic target; it does not interact with any known drugs and is considered non-coding and non-protein coding[1][4]. It is best classified as a non-coding RNA pseudogene found in the human genome.

Other names
RNU1-17PRNA, U1 small nuclear 17 pseudogeneU1 snRNA pseudogene
02

Biological functions

Potentially involved in RNA-based regulationPossible fine-tuning of pre-mRNA processing (as shown for other U1 snRNA pseudogenes)[4]
03

Disease associations

Other (no established direct disease association for RNU1-17P; some pseudogenes have evolved regulatory roles but causal links for this specific gene are not described)[4]

Beyond the preview

Go deeper on RNA, U1 small nuclear 17, pseudogene (RNU1-17P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U1 small nuclear 17, pseudogene (RNU1-17P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call